Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
51.72
-1.00 (-1.90%)
At close: Jul 20, 2026, 4:00 PM EDT
51.72
0.00 (0.00%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Alkermes Employees
Alkermes had 2,050 employees as of December 31, 2025. The number of employees increased by 250 or 13.89% compared to the previous year.
Employees
2,050
Change (1Y)
250
Growth (1Y)
13.89%
Revenue / Employee
$762,098
Profits / Employee
$74,498
Market Cap
8.62B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,050 | 250 | 13.89% |
| Dec 31, 2024 | 1,800 | -300 | -14.29% |
| Dec 31, 2023 | 2,100 | -180 | -7.89% |
| Dec 31, 2022 | 2,280 | 69 | 3.12% |
| Dec 31, 2021 | 2,211 | -34 | -1.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
| Lantheus Holdings | 1,193 |
ALKS News
- 11 hours ago - Alkermes price target raised to $63 from $45 at Stifel - TheFly
- 6 days ago - Alkermes to Report Second Quarter Financial Results on July 28, 2026 - Business Wire
- 7 days ago - Alkermes announces results from planned interim analysis of LTE of alixorexton - TheFly
- 7 days ago - Alkermes' Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis - Business Wire
- 7 days ago - Alkermes resumed with a Neutral at JPMorgan - TheFly
- 18 days ago - Alkermes price target raised to $65 from $53 at Mizuho - TheFly
- 21 days ago - Alkermes downgraded to Underperform from Neutral at BofA - TheFly
- 21 days ago - Alkermes price target raised to $65 from $44 at Wells Fargo - TheFly